ArticleAJPM focus2025
State Medical Cannabis Policy Implementation and Racial Disparities in Opioid Prescribing Among Medicare Beneficiaries: A Policy Impact Analysis.
Article in AJPM focus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Association between state cannabis laws and opioid outcomes: A systematic review.Drug and alcohol dependence · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: U.S. cannabis policies have a history of racial disparities, highlighting the need for research surrounding racial inequities, particularly within the context of medicalization of cannabis and opioid prescribing. This study evaluated racial disparities in the relationship between state-level medical cannabis policy implementation and changes in opioid-prescribing patterns among Medicare beneficiaries. Methods: Utilizing Medicare claims data from 2012 to 2015, beneficiaries aged ≥65 years were categorized into 3 state categories: Medical marijuana law implementation states, existing medical marijuana law states, and nonmedical marijuana law states. A difference-in-difference analysis was used to determine whether race moderated the relationship between medical cannabis policy implementation and opioid doses filled before and after policy implementation. Results: A total of 449,336 Medicare beneficiaries were included in the study, comprising 387,713 White individuals (86.3%) and 61,623 racial minority individuals (13.7%). Nearly half of all (49.3%) beneficiaries received at least 1 opioid prescription. White individuals were significantly more likely to receive at least 1 opioid prescription than racial minorities (49.7% vs 46.8%, Conclusions: The study found no clear indication of racial disparities in the impact of medical cannabis policies on opioid prescribing. Future research should focus on access to medical cannabis and prescriber attitudes toward treating racial minority patients experiencing pain with cannabis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.